Matthew Yan
Stock Analyst at CLSA
(3.40)
# 2,254
Out of 4,377 analysts
44
Total ratings
42.5%
Success rate
8.8%
Average return
Main Sectors:
Stocks Rated by Matthew Yan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HKG: 9995 RemeGen Co., Ltd. | Maintained: Buy | $103.00 → $136.90 | $70.50 | +94.18% | 5 | Mar 27, 2026 | |
| HKG: 1801 Innovent Biologics, Inc. | Maintained: Buy | $120.10 | $76.60 | +56.79% | 17 | Dec 8, 2025 | |
| HKG: 6160 BeOne Medicines AG | Maintained: Buy | $264.40 → $288.00 | $163.00 | +76.69% | 10 | Nov 7, 2025 | |
| HKG: 6990 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | Maintained: Buy | $548.60 | $393.40 | +39.45% | 3 | Oct 19, 2025 | |
| HKG: 9606 Duality Biotherapeutics, Inc. | Initiated Coverage: Buy | $268.30 | $186.60 | n/a | 1 | May 22, 2025 | |
| ONC BeOne Medicines AG | Maintained: Buy | $270 → $263 | $270.10 | n/a | 3 | Nov 13, 2024 | |
| TYO: 4568 Daiichi Sankyo Company, Limited | Maintained: Buy | ¥6,800 → ¥7,000 | $2,490.00 | n/a | 4 | Oct 31, 2024 | |
| HKG: 0013 HUTCHMED (China) Limited | Maintained: Buy | $40.77 | $17.64 | n/a | 1 | Aug 3, 2023 |
RemeGen Co., Ltd.
Mar 27, 2026
Maintained: Buy
Price Target: $103.00 → $136.90
Current: $70.50
Upside: +94.18%
Innovent Biologics, Inc.
Dec 8, 2025
Maintained: Buy
Price Target: $120.10
Current: $76.60
Upside: +56.79%
BeOne Medicines AG
Nov 7, 2025
Maintained: Buy
Price Target: $264.40 → $288.00
Current: $163.00
Upside: +76.69%
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Oct 19, 2025
Maintained: Buy
Price Target: $548.60
Current: $393.40
Upside: +39.45%
Duality Biotherapeutics, Inc.
May 22, 2025
Initiated Coverage: Buy
Price Target: $268.30
Current: $186.60
Upside: n/a
BeOne Medicines AG
Nov 13, 2024
Maintained: Buy
Price Target: $270 → $263
Current: $270.10
Upside: n/a
Daiichi Sankyo Company, Limited
Oct 31, 2024
Maintained: Buy
Price Target: ¥6,800 → ¥7,000
Current: $2,490.00
Upside: n/a
HUTCHMED (China) Limited
Aug 3, 2023
Maintained: Buy
Price Target: $40.77
Current: $17.64
Upside: n/a